AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹42 Cr | ₹41 Cr | ₹177 Cr | ₹285 Cr | ₹275 Cr |
What is the latest Total Non-Current Liabilities ratio of AJANTA PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹285 Cr |
| Mar2021 | ₹275 Cr |
How is Total Non-Current Liabilities of AJANTA PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 Cr | 3.21 | |
| Mar2024 | ₹41 Cr | -76.99 | |
| Mar2023 | ₹177 Cr | -37.77 | |
| Mar2022 | ₹285 Cr | 3.81 | |
| Mar2021 | ₹275 Cr | - | |
Compare Total Non-Current Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹35,125.6 Cr | 0.2% | -1.2% | 4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,439.0 Cr | 5.7% | -3.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,903.0 Cr | 1.6% | -7.6% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,466.0 Cr | -0.5% | 0.9% | 23.6% | Stock Analytics | |
| CIPLA | ₹107,653.0 Cr | 0.5% | -12.9% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,924.0 Cr | 5.3% | -0.9% | 1.9% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 0.2% |
-1.2% |
4.7% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses